Orenitram® (oral treprostinil) Extended Release Tablets
Orenitram is a prescription medicine used to treat pulmonary arterial hypertension (PAH) which is high blood pressure in the arteries of your lungs. Orenitram can help slow down the …
Orenitram: Uses, Dosage, Side Effects & Warnings - Drugs.com
Aug 22, 2023 · What is Orenitram? Orenitram is used in adults to treat certain kinds of pulmonary arterial hypertension (PAH; high blood pressure in the vessels carrying blood to the lungs, …
DailyMed - ORENITRAM- treprostinil tablet, extended release ORENITRAM ...
Nov 20, 2024 · Orenitram is an extended-release osmotic tablet for oral administration. Orenitram is formulated as the diolamine salt of treprostinil, a tricyclic benzindene analogue of prostacyclin.
Orenitram (Treprostinil Tablets): Side Effects, Uses, Dosage ...
Oct 16, 2024 · Orenitram (Treprostinil Tablets) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and …
Orenitram (treprostinil): Uses, Side Effects, Interactions ... - WebMD
Feb 5, 2025 · Find patient medical information for Orenitram (treprostinil) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings
Orenitram® (treprostinil) - Oral Prostacyclin Class Therapy
Orenitram is a prostacyclin mimetic indicated for treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to delay disease progression and to improve exercise capacity.
Orenitram® (oral treprostinil) Tablets For PAH - United …
Orenitram is a prescription oral medicine used to treat pulmonary arterial hypertension (PAH) which is high blood pressure in the arteries of your lungs. Orenitram can help slow down the …
Orenitram - Rare Disease Advisor
Feb 7, 2017 · Orenitram ® (oral treprostinil) is an extended-release oral tablet for the treatment of pulmonary arterial hypertension (PAH) (World Health Organization [WHO] group 1).
Orenitram: Package Insert / Prescribing Information / MOA
Dec 15, 2024 · Orenitram package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.
Orenitram (United Therapeutics Corporation): FDA Package Insert
Nov 20, 2024 · Orenitram is indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to delay disease progression and to improve exercise capacity.